1. Home
  2. PTGX vs CIVI Comparison

PTGX vs CIVI Comparison

Compare PTGX & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • CIVI
  • Stock Information
  • Founded
  • PTGX 2006
  • CIVI 1999
  • Country
  • PTGX United States
  • CIVI United States
  • Employees
  • PTGX N/A
  • CIVI N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • CIVI Oil & Gas Production
  • Sector
  • PTGX Health Care
  • CIVI Energy
  • Exchange
  • PTGX Nasdaq
  • CIVI Nasdaq
  • Market Cap
  • PTGX 2.9B
  • CIVI 2.5B
  • IPO Year
  • PTGX 2016
  • CIVI 2011
  • Fundamental
  • Price
  • PTGX $51.39
  • CIVI $29.73
  • Analyst Decision
  • PTGX Strong Buy
  • CIVI Buy
  • Analyst Count
  • PTGX 9
  • CIVI 12
  • Target Price
  • PTGX $67.11
  • CIVI $49.60
  • AVG Volume (30 Days)
  • PTGX 1.0M
  • CIVI 2.7M
  • Earning Date
  • PTGX 08-05-2025
  • CIVI 07-31-2025
  • Dividend Yield
  • PTGX N/A
  • CIVI 10.97%
  • EPS Growth
  • PTGX N/A
  • CIVI 5.61
  • EPS
  • PTGX 0.86
  • CIVI 8.73
  • Revenue
  • PTGX $207,801,000.00
  • CIVI $5,071,808,000.00
  • Revenue This Year
  • PTGX N/A
  • CIVI N/A
  • Revenue Next Year
  • PTGX $47.15
  • CIVI N/A
  • P/E Ratio
  • PTGX $64.57
  • CIVI $3.15
  • Revenue Growth
  • PTGX N/A
  • CIVI 22.15
  • 52 Week Low
  • PTGX $32.50
  • CIVI $22.79
  • 52 Week High
  • PTGX $60.60
  • CIVI $74.04
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.93
  • CIVI 41.70
  • Support Level
  • PTGX $52.16
  • CIVI $27.40
  • Resistance Level
  • PTGX $57.24
  • CIVI $33.34
  • Average True Range (ATR)
  • PTGX 1.71
  • CIVI 1.33
  • MACD
  • PTGX -0.25
  • CIVI -0.46
  • Stochastic Oscillator
  • PTGX 55.96
  • CIVI 7.96

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

Share on Social Networks: